Find Mufemilast manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1255909-03-5, Hemay005, 4qx9bk9e7p, Hemay-005, Refchem:159992, Mufemilast [inn]
Molecular Formula
C20H22N2O7S2
Molecular Weight
466.5  g/mol
InChI Key
PRSNGWLHNWGOKD-CQSZACIVSA-N
FDA UNII
4QX9BK9E7P

Mufemilast
a PDE4 inhibitor for the treatment of psoriasis
1 2D Structure

Mufemilast

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[5-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4,6-dioxothieno[3,4-c]pyrrol-3-yl]acetamide
2.1.2 InChI
InChI=1S/C20H22N2O7S2/c1-5-29-16-8-12(6-7-15(16)28-3)14(10-31(4,26)27)22-19(24)13-9-30-18(21-11(2)23)17(13)20(22)25/h6-9,14H,5,10H2,1-4H3,(H,21,23)/t14-/m1/s1
2.1.3 InChI Key
PRSNGWLHNWGOKD-CQSZACIVSA-N
2.2 Other Identifiers
2.2.1 UNII
4QX9BK9E7P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hemay005

2.3.2 Depositor-Supplied Synonyms

1. 1255909-03-5

2. Hemay005

3. 4qx9bk9e7p

4. Hemay-005

5. Refchem:159992

6. Mufemilast [inn]

7. Unii-4qx9bk9e7p

8. Acetamide, N-(5-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-5,6-dihydro-4,6-dioxo-4h-thieno(3,4-c)pyrrol-1-yl)-

9. Mufemilast [who-dd]

10. Orb1687054

11. Chembl5095240

12. Schembl20580068

13. Glxc-26950

14. Da-55763

15. Hy-145583

16. Cs-0376450

17. N-[5-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4,6-dioxothieno[3,4-c]pyrrol-3-yl]acetamide

2.4 Create Date
2019-03-16
3 Chemical and Physical Properties
Molecular Weight 466.5 g/mol
Molecular Formula C20H22N2O7S2
XLogP31.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area156
Heavy Atom Count31
Formal Charge0
Complexity813
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin.


Phosphodiesterase 4 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 4.


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty